Detalles de la búsqueda
1.
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
Antimicrob Agents Chemother
; 62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038282
2.
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.
J Antimicrob Chemother
; 73(8): 2112-2119, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746648
3.
Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
Clin Infect Dis
; 64(3): 317-325, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28013265
4.
Analysis of the Endogenous Deoxynucleoside Triphosphate Pool in HIV-Positive and -Negative Individuals Receiving Tenofovir-Emtricitabine.
Antimicrob Agents Chemother
; 60(9): 5387-92, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27353267
5.
Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
Antimicrob Agents Chemother
; 60(11): 6692-6697, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27572401
6.
Dose response for starting and stopping HIV preexposure prophylaxis for men who have sex with men.
Clin Infect Dis
; 60(5): 804-10, 2015 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25409469
7.
Associations Between Tenofovir Diphosphate in Dried Blood Spots, Impaired Physical Function, and Fracture Risk.
Open Forum Infect Dis
; 8(1): ofaa577, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33447638
8.
Among older adults, age-related changes in the stool microbiome differ by HIV-1 serostatus.
EBioMedicine
; 40: 583-594, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30685386
9.
Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring.
AIDS
; 32(15): 2189-2194, 2018 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30212404
10.
Brief Report: Adherence Biomarker Measurements in Older and Younger HIV-Infected Adults Receiving Tenofovir-Based Therapy.
J Acquir Immune Defic Syndr
; 77(3): 295-298, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29189417
11.
Inflammation and pharmacokinetics: potential implications for HIV-infection.
Expert Opin Drug Metab Toxicol
; 13(6): 641-650, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28335648
12.
Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates.
PLoS One
; 11(11): e0165505, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27832147
13.
Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State.
AIDS Res Hum Retroviruses
; 32(10-11): 981-991, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27526873
14.
Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.
AIDS Res Hum Retroviruses
; 31(10): 1015-22, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26059647
15.
Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.
J Acquir Immune Defic Syndr
; 68(5): 495-501, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25763783
Resultados
1 -
15
de 15
1
Próxima >
>>